Anti-ADAM9, Polyclonal [9HU]
Invented by Prof Carl Blobel from Hospital For Special Surgery At Weill Cornell Medicine
Invented at
- Datasheet
- References (2)
- Inventor Info
Info
Catalogue Number | 152530 |
Applications | WB |
Antigen/Gene or Protein Targets | ADAM9 |
Reactivity | Human |
Relevance | ADAM9 encodes disintegrin and metalloprotease (ADAM) domain 9, which is a member of the ADAM protein family. Members of this family are membrane- anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biologic processes involving cell- cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The member encoded by this gene interacts with SH3 domain-containing proteins, binds mitotic arrest deficient 2 beta protein, and is also involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. |
Host | Rabbit |
Immunogen | GST-cyto corresponding to the cytoplasmic domain of human ADAM9 |
Formulation | Whole serum |
Molecular Weight (kDa) | ~84 (mature form), 115 (pro-form) |
Notes | Suggested dilution for western blot: 1:1000 |
Research Area | Cancer, Cell Signaling & Signal Transduction |
References: 2 entries
Weskamp et al. 1996. J Cell Biol. 132(4):717-26. PMID: 8647900.
MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains.
Europe PMC ID: 8647900
Add a reference
References: 2 entries
Weskamp et al. 1996. J Cell Biol. 132(4):717-26. PMID: 8647900.
MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains.
Add a reference